What Are the Long-Term Prospects for Moderna?
There's no question that Moderna (NASDAQ: MRNA) is about to have a very good year financially. The biotech has major supply deals lined up for its COVID-19 vaccine and is hard at work cranking out millions of doses. But what are Moderna's long-term prospects? In this Motley Fool Live video recorded on Feb. 10, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how Moderna might fare going forward.
Source Fool.com


